Mesoblast faces FDA pushback
Mesoblast faces FDA pushback Source Reference The FDA will meet with Mesoblast to determine their...
Read MoreMesoblast faces FDA pushback Source Reference The FDA will meet with Mesoblast to determine their...
Read MoreThe FDA approved a Phase II trial for ExoFlo to treat patients with COVID-19. EXIT COVID-19 is a...
Read MoreFDA Approval for EXIT-COVID-19 Source Reference The FDA approved a Phase II trial to use the...
Read MoreManagement of of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells:...
Read MorePossible coronavirus treatment being researched Source Reference Dr. Michael Matthay started...
Read More